Literature DB >> 26657051

Clarification of vaccines: An overview of filter based technology trends and best practices.

Lise Besnard1, Virginie Fabre1, Michael Fettig2, Elina Gousseinov3, Yasuhiro Kawakami4, Nicolas Laroudie5, Claire Scanlan2, Priyabrata Pattnaik6.   

Abstract

Vaccines are derived from a variety of sources including tissue extracts, bacterial cells, virus particles, recombinant mammalian, yeast and insect cell produced proteins and nucleic acids. The most common method of vaccine production is based on an initial fermentation process followed by purification. Production of vaccines is a complex process involving many different steps and processes. Selection of the appropriate purification method is critical to achieving desired purity of the final product. Clarification of vaccines is a critical step that strongly impacts product recovery and subsequent downstream purification. There are several technologies that can be applied for vaccine clarification. Selection of a harvesting method and equipment depends on the type of cells, product being harvested, and properties of the process fluids. These techniques include membrane filtration (microfiltration, tangential-flow filtration), centrifugation, and depth filtration (normal flow filtration). Historically vaccine harvest clarification was usually achieved by centrifugation followed by depth filtration. Recently membrane based technologies have gained prominence in vaccine clarification. The increasing use of single-use technologies in upstream processes necessitated a shift in harvest strategies. This review offers a comprehensive view on different membrane based technologies and their application in vaccine clarification, outlines the challenges involved and presents the current state of best practices in the clarification of vaccines.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial vaccine; Clarification; Conjugated polysaccharide vaccine; Filtration; Harvest; Normal flow filtration; Purification; Tangential flow filtration; Vaccine; Viral vaccine

Mesh:

Substances:

Year:  2015        PMID: 26657051     DOI: 10.1016/j.biotechadv.2015.11.005

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  12 in total

Review 1.  Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

Review 2.  mRNA as a Therapeutics: Understanding mRNA Vaccines.

Authors:  Ferdi Oğuz; Harika Atmaca
Journal:  Adv Pharm Bull       Date:  2021-05-16

3.  Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors.

Authors:  Seiji Kuroda; Yoshitaka Miyagawa; Makoto Sukegawa; Taro Tomono; Motoko Yamamoto; Kumi Adachi; Gianluca Verlengia; William F Goins; Justus B Cohen; Joseph C Glorioso; Takashi Okada
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-13       Impact factor: 5.849

4.  Enhanced Production of Shigella flexneri Polysaccharide from a Newly Devised Silicate Method as a Potential Vaccine Conjugate.

Authors:  P V S L S S Narayana; Jayati Ray Dutta
Journal:  Curr Microbiol       Date:  2019-10-03       Impact factor: 2.188

5.  Cell-based influenza vaccine: current production, halal status assessment, and recommendations towards Islamic-compliant manufacturing.

Authors:  Nurul Nadiah Zulkarnain; Nurina Anuar; Norliza Abd Rahman; Siti Rozaimah Sheikh Abdullah; Muhammad Nazir Alias; Mashitoh Yaacob; Zhongren Ma; Gongtao Ding
Journal:  Hum Vaccin Immunother       Date:  2021-02-04       Impact factor: 3.452

6.  Evaluation of Host Cell Impurity Effects on the Performance of Sterile Filtration Processes for Therapeutic Viruses.

Authors:  Evan Wright; Karina Kawka; Maria Fe C Medina; David R Latulippe
Journal:  Membranes (Basel)       Date:  2022-03-24

7.  A Simplified and Efficient Process for Insulin Production in Pichia pastoris.

Authors:  Sulena Polez; Domenico Origi; Sotir Zahariev; Corrado Guarnaccia; Sergio G Tisminetzky; Nataša Skoko; Marco Baralle
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 8.  Purification Methods and the Presence of RNA in Virus Particles and Extracellular Vesicles.

Authors:  Yijun Zhou; Ryan P McNamara; Dirk P Dittmer
Journal:  Viruses       Date:  2020-08-21       Impact factor: 5.048

9.  Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus.

Authors:  Sanda Ravlić; Marija Brgles; Lea Hiršl; Stipan Jonjić; Beata Halassy
Journal:  Viruses       Date:  2021-12-10       Impact factor: 5.048

10.  Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus.

Authors:  Jason Gummow; Makutiro G Masavuli; Zelalem A Mekonnen; Yanrui Li; Danushka K Wijesundara; Ashish C Shrestha; Ilia Voskoboinik; Eric J Gowans; Branka Grubor-Bauk
Journal:  Vaccines (Basel)       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.